Preventive Cardiology

Preventive cardiology now spans far beyond statins and aspirin. Sessions cover risk stratification with coronary calcium, polygenic risk scores and inflammatory biomarkers; primary and secondary prevention guidelines; lifestyle, exercise and nutrition interventions; and emerging targets in residual risk including Lp(a) and clonal haematopoiesis. The track addresses the practical integration of GLP-1 agonists, SGLT2 inhibitors and combination lipid therapy into prevention pathways, plus the role of digital tools, wearables and community-based programmes in reaching at-risk populations.